Morepen Laboratories is currently trading at Rs. 62.06, up by 0.08 points or 0.13% from its previous closing of Rs. 61.98 on the BSE.
The scrip opened at Rs. 62.55 and has touched a high and low of Rs. 63.20 and Rs. 61.46 respectively. So far 532291 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 100.80 on 10-Sep-2024 and a 52 week low of Rs. 41.66 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs. 64.90 and Rs. 52.90 respectively. The current market cap of the company is Rs. 3402.24 crore.
The promoters holding in the company stood at 35.65%, while Institutions and Non-Institutions held 3.62% and 60.72% respectively.
Morepen Laboratories has received approval from Finance Committee of the Board of Directors to incorporate Wholly Owned Subsidiary of the Company in a Free Zone at Dubai, United Arab Emirates. The objective of incorporating the wholly owned subsidiary is to carry out the sales & marketing of company's products in international market through a Free Zone in Dubai, UAE.
The Finance Committee of the Board of Directors of the Company, at its meeting held on April 28, 2025 has approved the same.
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.
